References
1. Data on file [005], Connetics® Corporation.
2. Huang X, Tanojo H, Lenn J, Cuesico C, Deng H. Impact of vehicle on clobetasol propionate skin permeation and drug distribution in vitro. Poster presented at: American Academy of Dermatology 62nd Annual Meeting; February 6-11, 2004; Washington, DC. Poster 695.
3. Franz TJ, Parsell DA, Myers JA, Hannigan JF. Clobetasol propionate foam 0.05%: a novel vehicle with enhanced delivery. Int J Dermatol. 2000;39:535-538.
4. Huang X, Tanojo H, Lenn J, Deng CH, Krochmal, L. VersaFoam: A Novel Vehicle for the Delivery of Topical Corticosteroids. J Am Acad Dermatology: 2005;53:S26-38.
5. Gottlieb AB, Odom Ford R, Spellman MC. The Efficacy and Tolerability of Clobetasol Propionate Foam 0.05% in the Treatment of Mild to Moderate Plaque-type Psoriasis of Nonscalp Regions. J Cut Med Surgery: 2003:7:185-192.
Rebate Offer
Instantly save up to $35 off your OLUX® Foam prescription (even works with copay).
Patient Information Brochure
Download this helpful patient information brochure to learn more about OLUX and scalp dermatoses.